Concepedia

Publication | Open Access

Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)

DOIFull Paper Access

136

Citations

17

References

2021

Year

Jonathan Barratt, Branislav Andrić, Avtandil Tataradze, Michael Schömig, Michael Reusch, Udaya Valluri, Christophe Mariat
Nephrology Dialysis Transplantation

Abstract

Roxadustat is a viable option to treat anaemia in NDD CKD patients maintaining Hb levels for up to 104 weeks.

References

YearCitations

Page 1